31 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Acyclic tethers mimicking subunits of polysaccharide ligands: selectin antagonists.
Institut De Recherches Cliniques De Montr£Al (Ircm)
Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.
Pfizer
A new approach to explore the binding space of polysaccharide-based ligands: selectin antagonists.
TBA
Rational design of novel, potent small molecule pan-selectin antagonists.
Revotar Biopharmaceuticals
Development of potent non-carbohydrate imidazole-based small molecule selectin inhibitors with antiinflammatory activity.
Ontogen
Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269).
Texas Biotechnology
Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides.
Kanebo
Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides.
Kanebo
Sulfated galactocerebrosides as potential antiinflammatory agents.
Bristol-Myers Squibb Pharmaceutical Research Institute
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.
Institute Of Cancer Research
Studies on selectin blocker. 3. Investigation of the carbohydrate ligand sialyl Lewis X recognition site of P-selectin.
Kanebo
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.
New Drug Research Laboratory
Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (alpha-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids.
Texas Biotechnology
Design and synthesis of a new sialyl Lewis X mimetic: how selective are the selectin receptors?
Universit£
Synthesis of sialyl Lewis X mimetics using the Ugi four-component reaction.
Scripps Research Institute
Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury.
Pfizer
Synthesis of fluorinated C-mannopeptides as sialyl Lewisx mimics for E- and P-selectin inhibition.
Universit£
Isolation and structure determination of sulfonoquinovosyl dipalmitoyl glyceride, a P-selectin receptor inhibitor from the alga Dictyochloris fragrans.
Bristol-Myers Squibb Pharmaceutical Research Institute
2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists.
Wyeth Research
Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectin.
Wyeth
Sialyl Lewis(x) analogs based on a quinic acid scaffold as the fucose mimic.
National Chemical Engineering Institute In Paris
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Indian Institute Of Technology (B.H.U.)
Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist.
Organon K.K.
Cinnamamide: An insight into the pharmacological advances and structure-activity relationships.
National Institute Of Pharmaceutical Education And Research (Niper)
Selectin-ligand interactions revealed by molecular dynamics simulation in solution.
Kanebo